Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors—Preliminary Analysis

Afshar-Oromieh, 2013, PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions, Eur J Nucl Med Mol Imaging, 40, 486, 10.1007/s00259-012-2298-2

Afshar-Oromieh, 2015, The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer, Eur J Nucl Med Mol Imaging, 42, 197, 10.1007/s00259-014-2949-6

Eiber, 2015, Evaluation of hybrid 68Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy, J Nucl Med, 56, 668, 10.2967/jnumed.115.154153

Bluemel, 2016, 68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT, Clin Nucl Med, 41, 515, 10.1097/RLU.0000000000001197

Giesel, 2016, Intra-individual comparison of (68)Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer, Eur J Nucl Med Mol Imaging, 43, 1400, 10.1007/s00259-016-3346-0

Freitag, 2016, Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer, Eur J Nucl Med Mol Imaging, 43, 70, 10.1007/s00259-015-3206-3

Sterzing, 2016, (68)Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patients, Eur J Nucl Med Mol Imaging, 43, 34, 10.1007/s00259-015-3188-1

Silver, 1997, Prostate-specific membrane antigen expression in normal and malignant human tissues, Clin Cancer Res, 3, 81

Murphy, 1998, Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen, Cancer, 83, 2259, 10.1002/(SICI)1097-0142(19981201)83:11<2259::AID-CNCR5>3.0.CO;2-T

Ghosh, 2004, Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer, J Cell Biochem, 91, 528, 10.1002/jcb.10661

Chang, 1999, Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature, Cancer Res, 59, 3192

Chang, 1999, Prostate-specific membrane antigen is produced in tumor-associated neovasculature, Clin Cancer Res, 5, 2674

Demirci, 2014, (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma, Eur J Nucl Med Mol Imaging, 41, 1461, 10.1007/s00259-014-2766-y

Sasikumar, 2016, (68)Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma, Eur J Nucl Med Mol Imaging, 43, 795, 10.1007/s00259-015-3297-x

Sathekge, 2015, 68Ga-PSMA imaging of metastatic breast cancer, Eur J Nucl Med Mol Imaging, 42, 1482, 10.1007/s00259-015-3066-x

Sasikumar, 2016, 68Ga-PSMA PET/CT imaging and 153Sm-EDTMP bone pain palliation therapy, Clin Nucl Med, 41, e353, 10.1097/RLU.0000000000001230

Schwenck, 2015, In vivo visualization of prostate-specific membrane antigen in glioblastoma, Eur J Nucl Med Mol Imaging, 42, 170, 10.1007/s00259-014-2921-5

Taywade, 2016, PSMA expression in papillary thyroid carcinoma: opening a new horizon in management of thyroid cancer?, Clin Nucl Med, 41, e263, 10.1097/RLU.0000000000001148

Shetty, 2016, Elevated 68Ga prostate-specific membrane antigen activity in metastatic non-small cell lung cancer, Clin Nucl Med, 41, 414, 10.1097/RLU.0000000000001139

Huang, 2016, Rectal carcinoma on 68Ga-PSMA PET/CT, Clin Nucl Med, 41, e167, 10.1097/RLU.0000000000001072

Kanthan, 2016, Desmoid tumor showing intense uptake on 68Ga PSMA-HBED-CC PET/CT, Clin Nucl Med, 41, 508, 10.1097/RLU.0000000000001192

Kanthan, 2016, Follicular lymphoma showing avid uptake on 68Ga PSMA-HBED-CC PET/CT, Clin Nucl Med, 41, 500, 10.1097/RLU.0000000000001169

Kanthan, 2016, Follicular thyroid adenoma showing avid uptake on 68Ga PSMA-HBED-CC PET/CT, Clin Nucl Med, 41, 331, 10.1097/RLU.0000000000001084

Nomura, 2014, Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases, Cancer Cell Int, 14, 26, 10.1186/1475-2867-14-26

Nanabala, 2016, Preparation of [(68)Ga]PSMA-11 for PET-CT imaging using a manual synthesis module and organic matrix based (68)Ge/(68)Ga generator, Nucl Med Biol, 43, 463, 10.1016/j.nucmedbio.2016.05.006

Schwartzbaum, 2006, Epidemiology and molecular pathology of glioma, Nat Clin Pract Neurol, 2, 494, 10.1038/ncpneuro0289

Mabray, 2015, Modern brain tumor imaging, Brain Tumor Res Treat, 3, 8, 10.14791/btrt.2015.3.1.8

Coenen, 2010, Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences, Nucl Med Biol, 37, 727, 10.1016/j.nucmedbio.2010.04.185

Sharma, 2013, Overview of PET tracers for brain tumor imaging, PET Clin, 8, 129, 10.1016/j.cpet.2013.02.001

Prata, 2012, Gallium-68: a new trend in PET radiopharmacy, Curr Radiopharm, 5, 142, 10.2174/1874471011205020142

Sasikumar, 2016, 68Ga-PSMA PET/CT false-positive tracer uptake in Paget disease, Clin Nucl Med, 41, e454, 10.1097/RLU.0000000000001340

Gykiere, 2016, Healing sacral fracture masquerading as metastatic bone disease on a 68Ga-PSMA PET/CT, Clin Nucl Med, 41, e346, 10.1097/RLU.0000000000001222

Neri, 2005, Tumour vascular targeting, Nat Rev Cancer, 5, 436, 10.1038/nrc1627

Wernicke, 2011, Prostate-specific membrane antigen as a potential novel vascular target for treatment of glioblastoma multiforme, Arch Pathol Lab Med, 135, 1486, 10.5858/arpa.2010-0740-OA